Protocol for the Ketamine for Postoperative Avoidance of Depressive Symptoms (K-PASS) feasibility study: A randomized clinical trial

Authors

Bradley A Fritz, Washington University School of Medicine in St. Louis
Bethany R Tellor Pennington, Washington University School of Medicine in St. Louis
Ben J A Palanca, Washington University School of Medicine in St. Louis
Julie A Schweiger, Washington University School of Medicine in St. Louis
Jon T Willie, Washington University School of Medicine in St. Louis
Nuri B Farber, Washington University School of Medicine in St. Louis

Journal

F1000Research

Publication Date

1-1-2022

Volume

11

First Page

510

Document Type

Open Access Publication

DOI

10.12688/f1000research.121529.1

Rights and Permissions

Fritz BA, Tellor Pennington BR, Palanca BJA et al. Protocol for the Ketamine for Postoperative Avoidance of Depressive Symptoms (K-PASS) feasibility study: A randomized clinical trial [version 1; peer review: 2 approved]. F1000Research 2022, 11:510 (https://doi.org/10.12688/f1000research.121529.1) © 2022 Fritz BA et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Recommended Citation

Fritz, Bradley A; Tellor Pennington, Bethany R; Palanca, Ben J A; Schweiger, Julie A; Willie, Jon T; and Farber, Nuri B, "Protocol for the Ketamine for Postoperative Avoidance of Depressive Symptoms (K-PASS) feasibility study: A randomized clinical trial." F1000Research. 11, 510 (2022).
https://digitalcommons.wustl.edu/oa_4/2753

Department

ICTS (Institute of Clinical and Translational Sciences)